The grades of five Medical Devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
C.R. Bard (NYSE:BCR) is showing solid improvement this week. The company’s rating rises from a C (“hold”) to a B (“buy”). C. R. Bard is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. In Portfolio Grader’s specific subcategories of Earnings Momentum and Equity, BCR also gets A’s. For more information, get Portfolio Grader’s complete analysis of BCR stock.
The rating of Covidien (NYSE:COV) moves up this week, rising from a C to a B. Covidien is engaged in the development, manufacture, and sale of healthcare products, including pharmaceuticals and medical supplies, for use in clinical and home settings. For more information, get Portfolio Grader’s complete analysis of COV stock.
This week, Medtronic Inc. (NYSE:MDT) pushes up from a C to a B rating. Medtronic develops therapeutic and diagnostic medical products. For more information, get Portfolio Grader’s complete analysis of MDT stock.
China Kanghui (NYSE:KH) improves from a C to a B rating this week. China Kanghui engages in the development, manufacture, and sale of orthopedic implants and associated instruments for trauma, spine, cranial maxillofacial, and craniocerebral disorders. The stock price has risen 16.3% over the past month, better than the 1% increase the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of KH stock.
Novadaq Technologies (NASDAQ:NVDQ) is boosting its rating from a B (“buy”) to an A (“strong buy”) this week. Novadaq Technologies develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular and opthalmic diseases and conditions. Wall Street has pushed the stock higher by 41.1% over the past month. For more information, get Portfolio Grader’s complete analysis of NVDQ stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.